Two Sigma Advisers’s Strongbridge Biopharma plc. SBBP Stock Holding History

Two Sigma Advisers’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-150,600	Closed	-$307K	–	2897
2021 Q3	$307K	Sell	150,600 -102,000	-40%	-$237K	﹤0.01%	2109
2021 Q2	$750K	Sell	252,600 -182,000	-42%	-$481K	﹤0.01%	1763
2021 Q1	$1.2M	Sell	434,600 -62,200	-13%	-$188K	﹤0.01%	1555
2020 Q4	$1.21M	Buy	496,800 +160,300	+48%	+$386K	﹤0.01%	1480
2020 Q3	$707K	Buy	336,500 +247,700	+279%	+$835K	﹤0.01%	1665
2020 Q2	$336K	Buy	88,800 +59,000	+198%	+$177K	﹤0.01%	2076
2020 Q1	$56K	Buy	+29,800	New	+$77.5K	﹤0.01%	2367
2018 Q3	–	Sell	-12,600	Closed	-$76K	–	2460
2018 Q2	$76K	Buy	+12,600	New	+$92.2K	﹤0.01%	2289

Two Sigma Advisers's SBBP Position: Q4 2021 in Review

Two Sigma Advisers sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 150,600 shares — an estimated $307K sold.

Two Sigma Advisers first reported a position in SBBP in Q2 2018 and held it in 8 quarters. The position peaked at $1.21M in Q4 2020. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

Two Sigma Advisers reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
Two Sigma Advisers sold 150,600 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $307K.
Two Sigma Advisers first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 8 quarters.
Two Sigma Advisers's Strongbridge Biopharma plc. position peaked at $1.21M in Q4 2020.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.